Corebridge Financial (CRBD) CEO receives RSUs and stock options under 2022 plan

Rhea-AI Filing Summary

Corebridge Financial reported an equity compensation grant to its President & CEO and director. On December 1, 2025, the executive received 85,411 restricted stock units (RSUs)

The executive was also granted an employee stock option to purchase 314,861 shares of common stock at an exercise price of $29.75 per share. This option, also granted under the 2022 Omnibus Incentive Plan, vests in three equal annual installments beginning on December 1, 2026, subject to the executive remaining employed through each vesting date. Both grants are reported as exempt under Rule 16b-3, indicating they are standard equity incentive awards approved under a shareholder-approved plan.

12/02/2025 - 05:26 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Costantini Marc

(Last) (First) (Middle)

C/O COREBRIDGE FINANCIAL, INC.

2919 ALLEN PARKWAY, WOODSON TOWER

(Street)

HOUSTON TX 77019

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Corebridge Financial, Inc. [ CRBG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/01/2025		A		85,411(1)	A	$0	85,411(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$29.75	12/01/2025		A		314,861		(3)	12/01/2035	Common Stock	314,861	$0	314,861	D

Explanation of Responses:

1. On December 1, 2025, the Reporting Person received 85,411 Restricted Stock Units (RSUs) under the Corebridge Financial, Inc. (Corebridge) 2022 Omnibus Incentive Plan (2022 Incentive Plan) exempt under Rule 16b-3 that vest in equal installments on the first, second and third anniversaries of the grant date. Each RSU represents a contingent right to receive one share of common stock of Corebridge upon vesting, contingent upon the Reporting Person's continued employment at the conclusion of the vesting period.

2. Includes 85,411 RSUs.

3. Reflects employee stock option under the 2022 Incentive Plan exempt under Rule 16b-3. The employee stock option vests in three equal annual installments beginning on December 1, 2026, in each case, contingent upon the Reporting Person's continued employment at the conclusion of the vesting period.

Remarks:

	/s/ William Langston as Attorney-in-Fact	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Corebridge Financial (CRBD) grant to its CEO on December 1, 2025?

The President & CEO of Corebridge Financial received 85,411 restricted stock units (RSUs) and an employee stock option for 314,861 shares of common stock on December 1, 2025 under the 2022 Omnibus Incentive Plan.

How do the Corebridge Financial (CRBD) RSUs granted to the CEO vest?

The 85,411 RSUs granted to the CEO vest in three equal installments on the first, second, and third anniversaries of the December 1, 2025 grant date, contingent on continued employment.

What is the exercise price and vesting schedule of the Corebridge Financial (CRBD) stock options?

The employee stock option gives the CEO the right to buy 314,861 shares of Corebridge common stock at an exercise price of $29.75 per share, vesting in three equal annual installments beginning on December 1, 2026, subject to continued employment.

Are the Corebridge Financial (CRBD) CEO equity grants under a shareholder-approved plan?

Yes. Both the RSUs and the employee stock option were granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan, which is a shareholder-approved equity incentive plan.

Are the Corebridge Financial (CRBD) CEO equity awards exempt under Rule 16b-3?

Yes. The filing states that both the 85,411 RSUs and the employee stock option are exempt under Rule 16b-3, indicating they are standard compensatory awards approved under the company’s plan.